Stock Fundamentals

Company Information

▼
Company Name
Arcutis Biotherapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US03969K1088
CIK: 0001787306
CUSIP: 03969K108
Currency: USD
Full Time Employees: 354
Phone: 805 418 5006
Website: https://www.arcutis.com
Fiscal Year End: December
IPO Date: Jan 31, 2020
Description:

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Address:

3027 Townsgate Road, Westlake Village, CA, United States, 91361

Directors & Officers

▼
Name Title Year Born
Mr. Todd Franklin Watanabe M.A. President, CEO & Director 1968
Dr. Bhaskar Chaudhuri Ph.D. Co-Founder & Director Emeritus 1955
Mr. Masaru Matsuda Esq., J.D. Executive VP, Chief Legal Officer & Corporate Secretary 1971
Dr. Patrick E. Burnett M.D., Ph.D. Executive VP & Chief Medical Officer 1972
Mr. Larry Todd Edwards Executive VP & Chief Commercial Officer 1963
Ms. Latha Vairavan Chief Financial Officer NA
Mr. Rajvir Madan Chief Digital & Technology Officer NA
Mr. Brian Schoelkopf Head of Investor Relations NA
Mr. Steve Arias Vice President of Compliance & Privacy NA
Ms. Amanda Sheldon Head of Corporate Communications NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 11.96M Dec 31, 2025 9.65% $7.12 14.18%
Frazier Life Sciences Management, L.P. 9.87M Dec 31, 2025 7.96% $7.70 0.00%
BlackRock Inc 8.57M Sep 30, 2025 6.91% $0.00 0.48%
Rubric Capital Management LP 8.27M Dec 31, 2025 6.67% $2.87 -23.05%
Vanguard Group Inc 7.25M Dec 31, 2025 5.85% $0.00 1.51%
Jennison Associates LLC 6.76M Dec 31, 2025 5.45% $0.12 -44.85%
Polar Capital Holdings PLC 5.30M Sep 30, 2025 4.27% $0.48 5.84%
State Street Corp 4.64M Sep 30, 2025 3.74% $0.00 2.53%
Gilder Gagnon Howe & CO LLC 4.45M Dec 31, 2025 3.59% $1.37 0.56%
Morgan Stanley - Brokerage Accounts 4.28M Sep 30, 2025 3.45% $0.00 -0.88%
UBS Group AG 2.95M Sep 30, 2025 2.38% $0.01 0.36%
D. E. Shaw & Co LP 2.68M Dec 31, 2025 2.16% $0.04 26.64%
Geode Capital Management, LLC 2.61M Sep 30, 2025 2.10% $0.00 0.93%
Driehaus Capital Management LLC 2.56M Dec 31, 2025 2.07% $0.51 133.59%
HHG PLC 2.40M Sep 30, 2025 1.93% $0.02 5.92%
Franklin Resources Inc 2.31M Sep 30, 2025 1.86% $0.01 -15.43%
Pivotal bioVenture Partners Investment Advisor LLC 2.12M Sep 30, 2025 1.71% $23.11 0.00%
Ensign Peak Advisors Inc 1.90M Dec 31, 2025 1.53% $0.10 -4.55%
The Goldman Sachs Group Inc 1.80M Sep 30, 2025 1.46% $0.00 -4.51%
American Century Companies Inc 1.47M Dec 31, 2025 1.18% $0.02 -11.75%

Shares Statistics

▼
Shares Outstanding: 124.03M
Shares Float: 91.97M
% Insiders: 171.20%
% Institutions: 10,844.80%
Short % Float: 15.11%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Suvretta Capital Management, LLC 11.96M 9.65% ▲ 14.18% Dec 31, 2025
2 Frazier Life Sciences Management, L.P. 9.87M 7.96% ▲ 0.00% Dec 31, 2025
3 BlackRock Inc 8.57M 6.91% ▲ 0.48% Sep 30, 2025
4 Rubric Capital Management LP 8.27M 6.67% ▼ 23.05% Dec 31, 2025
5 Vanguard Group Inc 7.25M 5.85% ▲ 1.51% Dec 31, 2025
6 Jennison Associates LLC 6.76M 5.45% ▼ 44.85% Dec 31, 2025
7 Polar Capital Holdings PLC 5.30M 4.27% ▲ 5.84% Sep 30, 2025
8 State Street Corp 4.64M 3.74% ▲ 2.53% Sep 30, 2025
9 Gilder Gagnon Howe & CO LLC 4.45M 3.59% ▲ 0.56% Dec 31, 2025
10 Morgan Stanley - Brokerage Accounts 4.28M 3.45% ▼ 0.88% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $2.73B
Trailing P/E: 0.00
Forward P/E: 126.58

Financial Highlights

▼
Market Cap: $2.84B
EBITDA: $-7.56M
Book Value: $1.54
Earnings/Share: $-0.13
Profit Margin: -4.29%
Operating Margin: 14.20%
ROA (TTM): -1.96%
ROE (TTM): -9.30%
Revenue (TTM): $376.07M
Revenue/Share (TTM): $2.96
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 81.50%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.17x 0.58x 0.56x -1.01x 43.94x
2024-12-31 4.15x 0.69x 0.55x -4.73x -0.99x
2023-12-31 7.08x 2.28x 0.74x -8.11x -0.89x
2022-12-31 11.57x 0.95x 0.53x -19.27x -0.68x
2021-12-31 12.09x 0.24x 0.27x -454.91x -0.35x
2020-12-31 12.96x 0.00x 0.09x N/A 0.00x
2019-12-31 20.33x 0.00x 0.05x N/A 0.00x
2018-12-31 19.12x 0.00x 1.47x N/A 0.00x
2017-12-31 5.52x -0.19x 2.31x N/A -0.24x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 02, 2026 Latha Vairavan N/A Sale 2.85K $25.18 $71.84K
Mar 02, 2026 Masaru Matsuda N/A Sale 8.73K $25.30 $220.94K
Mar 02, 2026 Patrick Burnett N/A Sale 6.29K $25.18 $158.31K
Mar 02, 2026 Todd Watanabe N/A Sale 37.35K $25.18 $940.45K
Mar 02, 2026 Larry Todd Edwards N/A Sale 3.69K $25.18 $92.84K
Feb 27, 2026 Masaru Matsuda N/A Sale 3.33K $27.95 $92.93K
Feb 04, 2026 Patrick Burnett N/A Sale 9.79K $25.81 $252.78K
Feb 02, 2026 Masaru Matsuda N/A Sale 40.64K $25.28 $1.03M
Feb 02, 2026 Todd Watanabe N/A Sale 19.83K $25.50 $505.74K
Feb 02, 2026 Patrick Burnett N/A Sale 3.68K $25.50 $93.71K
Feb 02, 2026 Latha Vairavan N/A Sale 1.32K $25.50 $33.66K
Feb 02, 2026 Larry Todd Edwards N/A Sale 2.05K $25.50 $52.33K
Feb 02, 2026 Howard G Welgus N/A Sale 10.00K $25.05 $250.50K
Jan 05, 2026 Patrick Burnett N/A Sale 2.49K $28.98 $72.16K
Jan 02, 2026 Howard G Welgus N/A Sale 10.00K $28.96 $289.60K
Dec 31, 2025 Patrick Burnett N/A Sale 1.70K $29.20 $49.55K
Dec 15, 2025 Patrick Burnett N/A Sale 11.50K $28.94 $332.81K
Dec 11, 2025 Gilbert Ray Cisneros, Jr. N/A Sale N/A $29.47 N/A
Dec 01, 2025 Howard G Welgus N/A Sale 10.00K $30.21 $302.10K
Dec 01, 2025 Masaru Matsuda N/A Sale 1.66K $30.23 $50.09K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ARQT.US!